Document is current
Any future updates will be listed below
-
Authors
Van Rossem, Deborah
Allemeersch, Gert-Jan
Barros, Nuno
Temmerman, Joke
Desmet, Marijke
Ringoot, Ilka
Ribbens, Annemie
Michiels, Veronique
De Mey, Johan
Baeken, Chris
Engelborghs, Sebastiaan
De Witte, Sara
-
Funding
Funding for this research was provided by:
the Geneeskundige Stichting Koningin Elisabeth / Fondation Médicale Reine Elisabeth
- License Information
-
More Information
Article History
Received: 12 February 2025
Accepted: 21 July 2025
First Online: 26 September 2025
Declarations
:
: S. E. received research grants from Interreg Vlaanderen-Nederland, Research Foundation Flanders (FWO), VLAIO, GSKE/FMRE (paid to institution), consulting fees from Icometrix, Novartis, Eisai (paid to institution), personal consulting fees from Roche and Biogen, personal honoraria from Eli Lilly, Roche, travel support to institution from Biogen, Eli Lilly, Patent EP3452830B1 (institution), member of SMB/SAB for EU-H2020 project RECAGE. VP of Belgian Dementia Council, co-chair of European Alzheimer Disease Consortium and co-chair of the European Academy of Neurology Scientific Panel ‘Dementia and Cognitive Disorders’ (all unpaid). N. B. and A. R. are employees of Icometrix. The other authors declare that they have no competing interests.
